Resultados de la búsqueda

Semerano A, Fernández-Ruiz J, Cortes-Canteli M, Moro MA. rom Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline. Br J Pharmacol (2024) 181:755-759
Link to the full text in Repisalud

Fernández-Tocino M, Pun-Garcia A, Gómez M, Clemente-Moragón A, Oliver E, Villena-Gutierrez R, Trigo-Anca S, Díaz-Guerra A, Sanz-Rosa D, Prados B, Del Campo L, Andrés V, Fuster V, de la Pompa JL, Cádiz L, Ibañez B. β3-Adrenergic receptor overexpression in cardiomyocytes preconditions mitochondria to withstand ischemia-reperfusion injury. Basic Res Cardiol (2024) 119:773-794

Moreno-Arciniegas A, Cádiz L, Galán-Arriola C, Clemente-Moragón A, Ibáñez B. Cardioprotection strategies for anthracycline cardiotoxicity. Basic Res Cardiol (2024) Sep 9 [Epub ahead of print]

Domínguez F, Uribarri A, Larrañaga-Moreira JM, Ruiz-Guerrero L, Pastor-Pueyo P, Gayán-Ordás J, Fernández-González B, Esteban-Fernández A, Barreiro M, López-Fernández S, Gutiérrez-Larraya Aguado F, Pascual-Figal D; Working Group on Myocarditis of the Spanish Society of Cardiology. Diagnosis and treatment of myocarditis and inflammatory cardiomyopathy. Consensus document of the SEC-Working Group on Myocarditis. Rev Esp Cardiol (2024) S1885-5857:00156-7.

Pastor-Pérez FJ, Garrido-Bravo IP, Peñafiel-Verdú P, Fernández-Villa N, Manzano-Fernández S, Oliva-Sandoval MJ, Pérez-Martínez MT, Caro-Martínez C, Hernández-Vicente Á, Pascual-Figal DA; clinical trial REMOVE researches. Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial. Rev Esp Cardiol (2024) 77:851-858

Tristão-Pereira C, Fuster V, Lopez-Jimenez A, Fernández-Pena A, Semerano A, Fernandez-Nueda I, Garcia-Lunar I, Ayuso C, Sanchez-Gonzalez J, Ibanez B, Gispert JD, Cortes-Canteli M. Subclinical atherosclerosis and brain health in midlife: Rationale and design of the PESA-Brain study. Am Heart J (2024) 278:195-207

Lamanna-Rama N, Romero-Miguel D, Casquero-Veiga M, MacDowell KS, Santa-Marta C, Torres-Sánchez S, Berrocoso E, Leza JC, Desco M, Soto-Montenegro ML. THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation. PSYCHIAT RES (2024) 331:115643

Domingo-Gardeta T, Montero-Cabezas JM, Jurado-Román A, Sabaté M, Aboal J, Baranchuk A, Carrillo X, García-Zamora S, Dores H, van der Valk V, Scherptong RWC, Andrés-Cordón JF, Vidal P, Moreno-Martínez D, Toribio-Fernández R, Lillo-Castellano JM, Cruz R, De Guio F, Marina-Breysse M, Martínez-Sellés M. Rationale and design of the artificial intelligence scalable solution for acute myocardial infarction (ASSIST) study. J Electrocardiol (2024) 86:153768

Romero-Miguel D, Casquero-Veiga M, Lamanna-Rama N, Torres-Sánchez S, MacDowell KS, García-Partida JA, Santa-Marta C, Berrocoso E, Leza JC, Desco M, Soto-Montenegro ML. N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia Transl Psychiatry (2024) 14:14
Link to the full text in Repisalud

Aguzzoli Peres F, Haas AN, Martha AD, Chan M, Steele M, Ferretti MT, Ngcobo NN, Ilinca S, Domínguez-Vivero C, Leroi I, Sajnani N, Zimmer ER, Kornhuber A, Kalache A, Holtzhausen B, Tristão-Pereira C, Dupont C, Cohen D, de Jong D, Facal D, O'Sullivan D, Mateus E, Roso E, Estrop E, Gamba G, San Martin Elexpe G, Ulises Diaz Hernández H, Quaid H, Govia I, Barbosa J, García Del Moral J, Miller J, García García JA, Quaid K, Navarro L, García LZ, Waters L, Molete L, Godoy ME, Sigauke M, de Ataide Schulte MW, Estrop P, San Martin Elexpe Cardoso P, Perez R, Patterson R, Chakrabarti R, Wong R, Marsillas S, Lowe S, Rego TS, Farombi T, Montgomery T, In 't Veen T, Yanni V, Weidner W, Ibanez A. Walking the talk for dementia: A unique immersive, embodied, and multi-experiential initiative. Alzheimers Dement (2024) 20:2309-2322
Link to the full text in Repisalud